We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

131 hedge funds and large institutions have $829M invested in Intra-Cellular Therapies Inc. in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 47 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more capital invested

Capital invested by funds: $553M → $829M (+$276M)

47% more call options, than puts

Call options by funds: $30.8M | Put options by funds: $21M

5% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 19

0% more funds holding

Funds holding: 131 → 131 (0)

13% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 47

Holders
131
Holders Change
–
Holders Change %
0%
% of All Funds
3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
41
Reduced
47
Closed
19
Calls
$30.8M
Puts
$21M
Net Calls
+$9.81M
Net Calls Change
+$5.83M

Top Buyers

1
PC
PointState Capital
New York
+$36.4M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$21.8M
3
Citadel Advisors
Citadel Advisors
Florida
+$18.9M
4
DFO
Duquesne Family Office
New York
+$5.79M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$5.69M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$17.2M
2
BBA
Baker Bros. Advisors
New York
-$8.82M
3
SC
Samlyn Capital
New York
-$6.83M
4
RPAM
Rhenman & Partners Asset Management
Sweden
-$5.69M
5
BlackRock
BlackRock
New York
-$4.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
DBT
126
Dubuque Bank & Trust
Iowa
$5K – – –
LTFS
127
Ladenburg Thalmann Financial Services
Florida
$3K – – –
PNC Financial Services Group
128
PNC Financial Services Group
Pennsylvania
$2K – – –
LF
129
Lee Financial
Texas
$2K +$1.62K +83 New
HMS
130
Hanseatic Management Services
New Mexico
$1K – – –
SWP
131
Stratos Wealth Partners
Ohio
$1K +$643 +33 New
BBA
132
Baker Bros. Advisors
New York
– -$8.82M -609,166 Closed
BI
133
BVF Inc
California
– -$3.96M -273,350 Closed
JGC
134
J. Goldman & Co
New York
– -$3.61M -249,274 Closed
LCM
135
Laurion Capital Management
New York
– -$3.27M -226,160 Closed
ARTA
136
A.R.T. Advisors
New York
– -$1.17M -81,010 Closed
American Century Companies
137
American Century Companies
Missouri
– -$946K -65,330 Closed
SCA
138
Secor Capital Advisors
New York
– -$834K -57,628 Closed
Tudor Investment Corp
139
Tudor Investment Corp
Connecticut
– -$463K -31,965 Closed
GH
140
GAM Holding
Switzerland
– -$445K -30,700 Closed
FRM
141
Fox Run Management
Connecticut
– -$386K -26,625 Closed
EMG
142
Ellington Management Group
Connecticut
– -$246K -17,000 Closed
Jacobs Levy Equity Management
143
Jacobs Levy Equity Management
New Jersey
– -$243K -16,770 Closed
Connor, Clark & Lunn Investment Management (CC&L)
144
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$165K -11,425 Closed
Parallax Volatility Advisers
145
Parallax Volatility Advisers
California
– -$146K -10,110 Closed
Russell Investments Group
146
Russell Investments Group
United Kingdom
– -$94K -6,200 Closed
Acadian Asset Management
147
Acadian Asset Management
Massachusetts
– -$24K -1,657 Closed
NIT
148
NumerixS Investment Technologies
British Columbia, Canada
– -$16K -1,100 Closed
EWM
149
Endurance Wealth Management
Rhode Island
– -$5K -325 Closed
AP
150
Atwood & Palmer
Missouri
– -$3K -200 Closed
2 3 4 5
6

ITCI Hedge Fund Activity: Q1 2018 in Review

131 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q1 2018, worth a combined $829M — up 50% from $553M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new ITCI positions and 19 closed out — a net gain of 1 holder — while 41 added to existing stakes and 47 trimmed.

The largest buyer was PointState Capital, opening a new position worth an estimated $36.4M. The largest seller was Millennium Management, cutting an estimated $17.2M.

  • 131 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $829M of Intra-Cellular Therapies Inc. stock for Q1 2018, up 50% quarter-over-quarter.
  • 20 funds opened new Intra-Cellular Therapies Inc. positions in Q1 2018 and 19 closed out, a net change of +1 holder.
  • The largest Intra-Cellular Therapies Inc. buyer in Q1 2018 was PointState Capital, an estimated $36.4M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q1 2018 was Millennium Management, an estimated $17.2M sold.

Based on aggregated 13F filings for Q1 2018.